Not Tagged
Not Tagged
['2018']
existing surveillance guidelines are mostly based on guidelines for hsct after malignancy &amp; are mostly consensus based. this is a call for a registry of data after gene editing/gene therapy and post-sct. ( has put out some in their 2021 guide for #scd) 7/n #ash22 
Peds hem/onc enthusiast with interest in med ed (and now a PD @ UCSF), QI & safety, hemostasis/thrombosis. Former Saipan pediatrician. Tweets are my own